A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors
NCT01610479 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2017-08-04
Summary
This is a phase 1 study of TAS-114 in combination with S-1 in patients with advanced solid tumors.
Conditions
Interventions
- DRUG
-
TAS-114 + S-1
Sponsors & Collaborators
-
Taiho Pharmaceutical Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-06-30
- Primary Completion
- 2017-02-28
- Completion
- 2017-02-28
Countries
- Japan
Study Locations
More Related Trials
-
TR64 in Patients With Advanced Solid Tumors
NCT05649345 ·Status: RECRUITING ·Phase: PHASE1
-
A Clinical Study of SPH6516 Tablets in the Treatment of Advanced Solid Tumors.
NCT06266923 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study of Niraparib as Single Agent in Participants With Advanced Solid Tumors
NCT03497429 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer
NCT04982926 ·Status: TERMINATED ·Phase: PHASE1
-
MEDI5752 in Japanese Patients With Advanced Solid Tumors.
NCT05685472 ·Status: COMPLETED ·Phase: PHASE1
-
TR128 in Patients With Advanced Solid Tumors
NCT05751356 ·Status: RECRUITING ·Phase: PHASE1
-
TT-00973-MS Tablets in Patients With Advanced Solid Tumors
NCT05673538 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors
NCT03343054 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Tafetinib in Chinese Patients With Advanced Solid Tumor
NCT02717741 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of PM1022 in Patients With Advanced Tumors
NCT05867771 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Clinical Study of TQB3912 Tablets in Patients With Advanced Malignant Tumor
NCT05997342 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of TWP-101 in Patients With Advanced Melanoma and Urothelial Carcinoma
NCT04871334 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid Tumors
NCT06238687 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase Ib Study of Primary Efficacy and Safety of IBI321 Monotherapy or Combination Therapy in Patients With Advanced Solid Tumors
NCT05172856 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients
NCT06010342 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Trilaciclib Combined With Chemotherapy in the Treatment of NSCLC
NCT06328049 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Trial of TQB3002 in Patients With Advanced Cancers
NCT06662760 ·Status: RECRUITING ·Phase: PHASE1
-
A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors.
NCT06487455 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors
NCT07071090 ·Status: RECRUITING ·Phase: PHASE1
-
Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors
NCT05740215 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study of TQB3455 Tablets in Subjects With Advanced Malignancies
NCT04340427 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study Of The Pharmacokinetics And Safety Of Ipatasertib In Chinese Participants With Locally Advanced Or Metastatic Solid Tumors.
NCT04341259 ·Status: COMPLETED ·Phase: PHASE1
-
A Dose Escalation and Dose Expansion Clinical Study of STI-7349 in Subjects With Advanced Solid Tumors
NCT05978102 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of NIB101 in Participants With Advanced Solid Tumors
NCT05192174 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of the Safety and Efficacy of NBL-015 in Patients With Advanced Solid Tumors
NCT05153096 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1